SLHN Stock Analysis: Swiss Life Holding | SW
Insurance - Diversified | SW, Switzerland | Market Cap: 24.693m CHF | 12M Return: 6.1% | CH0014852781 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 42.9M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Swiss Life Holding AG is a Zurich-headquartered insurance and financial services group founded in 1857. It operates across Switzerland, France, Germany, the United Kingdom, and Luxembourg through six reportable segments: Switzerland, France, Germany, International, Asset Managers, and Other.
The companys core offering centers on life insurance, pensions, annuities, and investment-type policies for both private and corporate clients, supplemented by health, disability, property and casualty, liability, motor, accident, and payment protection coverage. Multi-line insurers of this type typically collect premiums while simultaneously managing large investment portfolios backed by policyholder reserves, making asset management a structural feature of the business rather than a side activity.
Beyond underwriting, the group runs internal and external asset management and advisory services, and is active in adjacent areas including private equity, real estate, banking, reinsurance, brokering, and investment funds. Distribution combines a proprietary sales force with partner networks, with products marketed under brands such as Swiss Life Select, Tecis, Horbach, Proventus, and Chase de Vere.
- Higher interest rates lift investment margin on bond portfolio
- Fee income expands as Assets under Management grow across segments
- Capital return accelerates via dividends and share buybacks
| Net Income: 1.29b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.39 > 1.0 |
| NWC/Revenue: -794.3% < 20% (prev -1.79k%; Δ 994.1% < -1%) |
| CFO/TA 0.01 > 3% & CFO 1.89b > Net Income 1.29b |
| Net Debt (11.5b) to EBITDA (1.74b): 6.61 < 3 |
| Current Ratio: 0.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.0m) vs 12m ago -3.40% < -2% |
| Gross Margin: 81.01% > 18% (prev 100.0%; Δ -18.99% > 0.5%) |
| Asset Turnover: 9.06% > 50% (prev 2.69%; Δ 6.37% > 0%) |
| Interest Coverage Ratio: 6.29 > 6 (EBIT TTM 1.74b / Interest Expense TTM 276.0m) |
| A: -0.70 (Total Current Assets 6.99b - Total Current Liabilities 166b) / Total Assets 227b |
| B: 0.04 (Retained Earnings 8.63b / Total Assets 227b) |
| C: 0.01 (EBIT TTM 1.74b / Avg Total Assets 221b) |
| D: 0.03 (Book Value of Equity 6.31b / Total Liabilities 220b) |
| Altman-Z'' = -4.40 = D |
| DSRI: 0.22 (Receivables 1.95b/2.61b, Revenue 20.1b/5.82b) |
| GMI: 1.23 (GM 100.0% / 81.01%) |
| AQI: 1.34 (AQ_t 0.96 / AQ_t-1 0.72) |
| SGI: 3.45 (Revenue 20.1b / 5.82b) |
| TATA: -0.00 (NI 1.29b - CFO 1.89b) / TA 227b) |
| Beneish M = -1.50 (Cap -4..+1) = CCC |
As of October 10, 2026, the stock is trading at CHF 881.40 with a total of 53,952 shares traded. Over the past week, the price has changed by -0.25%, over one month by -4.61%, over three months by -3.97% and over the past year by +6.06%.
Current recommended Stop Loss: 862.10 (which is 2.2% or 1.5 ATR below the current price).
Swiss Life Holding has no consensus analysts rating.
P/E Trailing = 19.238
P/E Forward = 17.5439
P/S = 2.074
P/B = 4.0083
P/EG = 2.2796
Revenue TTM = 20.1b CHF
EBIT TTM = 1.74b CHF
EBITDA TTM = 1.74b CHF
Long Term Debt = 10.3b CHF (from longTermDebt, last quarter)
Short Term Debt = 5.78b CHF (from shortTermDebt, last quarter)
Debt = 16.5b CHF (from shortLongTermDebtTotal, last quarter) + Leases 215.0m
Net Debt = 11.5b CHF (calculated: Debt 16.5b - CCE 5.04b)
Enterprise Value = 36.2b CHF (24.7b + Debt 16.5b - CCE 5.04b)
Interest Coverage Ratio = 6.29 (Ebit TTM 1.74b / Interest Expense TTM 276.0m)
EV/FCF = 20.08x (Enterprise Value 36.2b / FCF TTM 1.80b)
FCF Yield = 4.98% (FCF TTM 1.80b / Enterprise Value 36.2b)
FCF Margin = 8.98% (FCF TTM 1.80b / Revenue TTM 20.1b)
Net Margin = 6.44% (Net Income TTM 1.29b / Revenue TTM 20.1b)
Gross Margin = 81.01% ((Revenue TTM 20.1b - Cost of Revenue TTM 3.81b) / Revenue TTM)
Gross Margin QoQ = 50.63% (prev none%)
Tobins Q-Ratio = 0.16 (Enterprise Value 36.2b / Total Assets 227b)
Interest Expense / Debt = 1.67% (Interest Expense 276.0m / Debt 16.5b)
Taxrate = 24.99% (434.0m / 1.74b)
NOPAT = 1.30b (EBIT 1.74b * (1 - 24.99%))
Current Ratio = 0.04 (Total Current Assets 6.99b / Total Current Liabilities 166b)
Debt / Equity = 2.62 (Debt 16.5b / totalStockholderEquity, last quarter 6.31b)
Debt / EBITDA = 6.61 (Net Debt 11.5b / EBITDA 1.74b)
Debt / FCF = 6.37 (Net Debt 11.5b / FCF TTM 1.80b)
Total Stockholder Equity = 6.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.58% (Net Income 1.29b / Total Assets 227b)
RoE = 18.64% (Net Income TTM 1.29b / Total Stockholder Equity 6.93b)
RoCE = 10.07% (EBIT 1.74b / Capital Employed (Equity 6.93b + L.T.Debt 10.3b))
RoIC = 2.00% (NOPAT 1.30b / Invested Capital 65.1b)
WACC = 4.23% (E(24.7b)/V(41.2b) * Re(6.23%) + D(16.5b)/V(41.2b) * Rd(1.67%) * (1-Tc(0.25)))
Discount Rate = 6.23% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.56 | Cagr: -4.33%
[DCF] Terminal Value 77.97% ; FCFF base≈1.43b ; Y1≈1.64b ; Y5≈2.41b
[DCF] Fair Price = 886.3 (EV 36.2b - Net Debt 11.5b = Equity 24.8b / Shares 27.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 8.83 | Revenue CAGR: 4.18% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=47.66 | Chg30d=+0.82% | Revisions=+12% | GrowthEPS=+9.6% | GrowthRev=+2.6%
EPS next Year (2027-12-31): EPS=51.33 | Chg30d=+0.73% | Revisions=+12% | GrowthEPS=+7.7% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: +15% (up=6, down=4)